BlackRock Form 4: Senior MD Rachel Lord disposes 18k shares
Rhea-AI Filing Summary
On 25 Jul 2025, BlackRock (BLK) Senior Managing Director Rachel Lord filed a Form 4 disclosing a cashless exercise and sale of employee stock options. She exercised 18,036 options at a strike price of $513.50 (Code M) and immediately sold the same number of common shares in seven open-market transactions (Code S) at weighted-average prices ranging from $1,123.35 to $1,129.61. Gross sale value is roughly $20 million, while no derivative securities remain outstanding from the grant that fully vested between 2022-2024.
Following the transactions, Lord’s direct beneficial ownership fell from 37,241 to 19,205 shares, a reduction of 18,036 shares (≈0.01 % of BLK shares outstanding). The remaining holding includes restricted stock units that will vest over the next one to three years. No Rule 10b5-1 trading plan or purchase activity was disclosed.
Positive
- None.
Negative
- 18,036 shares sold by a senior executive may be interpreted as a modest bearish signal, although the amount is immaterial to BLK’s float.
Insights
TL;DR: Insider exercised options and sold 18k shares, modest size vs. float; neutral-to-slightly bearish signal.
The filing shows a classic option exercise-and-sell: Lord paid $513.50 to acquire 18,036 shares, then liquidated them at ≈$1,125, realizing a spread of ~$611 per share. Although the dollar amount (~$20 m) is notable for the individual, it represents only 0.01 % of BlackRock’s 152 m share base and should have negligible effect on supply-demand dynamics. Because no concurrent purchases were reported, the market may view the action as routine diversification rather than a positive commitment. Impact: neutral.
TL;DR: Routine Section 16 disposition; no policy red flags, limited governance impact.
This Form 4 follows standard Section 16 reporting, signed by an attorney-in-fact. The exercise fully closes out a 2019 option grant that had already vested. Lord retains >19 k shares plus RSUs, preserving alignment with shareholders. The absence of a disclosed 10b5-1 plan means trades were discretionary, yet volume is too small to signal strategic shifts. Governance risk is minimal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 18,036 | $0.00 | -- |
| Exercise | Common Stock | 18,036 | $513.50 | $9.26M |
| Sale | Common Stock | 6,437 | $1,123.3479 | $7.23M |
| Sale | Common Stock | 2,476 | $1,124.5604 | $2.78M |
| Sale | Common Stock | 900 | $1,125.5294 | $1.01M |
| Sale | Common Stock | 2,407 | $1,126.8217 | $2.71M |
| Sale | Common Stock | 4,041 | $1,127.5537 | $4.56M |
| Sale | Common Stock | 946 | $1,128.7149 | $1.07M |
| Sale | Common Stock | 829 | $1,129.6128 | $936K |
Footnotes (1)
- Includes Common Stock as well as Restricted Stock Units that will vest over a period of 1 to 3 years. Each Restricted Stock Unit is payable solely by delivery of an equal number of shares of Common Stock. This transaction was executed in multiple trades at prices ranging from $1,122.96 to $1,123.95. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,124.00 to $1,125.00. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,125.01 to $1,126.01. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,126.22 to $1,127.21. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,127.23 to $1,128.15. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,128.27 to $1,129.25. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,129.38 to $1,129.83. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. These options vested in equal installments on December 4, 2022, December 4, 2023 and December 4, 2024.
